AR025398A1 - Aglomerados esfericos de telitromicina, su procedimiento de preparacion y su aplicacion en la preparacion de formas farmaceuticas. - Google Patents

Aglomerados esfericos de telitromicina, su procedimiento de preparacion y su aplicacion en la preparacion de formas farmaceuticas.

Info

Publication number
AR025398A1
AR025398A1 ARP000104426A ARP000104426A AR025398A1 AR 025398 A1 AR025398 A1 AR 025398A1 AR P000104426 A ARP000104426 A AR P000104426A AR P000104426 A ARP000104426 A AR P000104426A AR 025398 A1 AR025398 A1 AR 025398A1
Authority
AR
Argentina
Prior art keywords
preparation
application
telitromycin
pharmaceutical forms
spherical agricultural
Prior art date
Application number
ARP000104426A
Other languages
English (en)
Spanish (es)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR025398(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR025398A1 publication Critical patent/AR025398A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ARP000104426A 1999-08-26 2000-08-25 Aglomerados esfericos de telitromicina, su procedimiento de preparacion y su aplicacion en la preparacion de formas farmaceuticas. AR025398A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (1)

Publication Number Publication Date
AR025398A1 true AR025398A1 (es) 2002-11-27

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104426A AR025398A1 (es) 1999-08-26 2000-08-25 Aglomerados esfericos de telitromicina, su procedimiento de preparacion y su aplicacion en la preparacion de formas farmaceuticas.

Country Status (34)

Country Link
US (1) US6825218B1 (enExample)
EP (1) EP1212336B1 (enExample)
JP (1) JP4871467B2 (enExample)
KR (1) KR100718222B1 (enExample)
CN (1) CN1183151C (enExample)
AR (1) AR025398A1 (enExample)
AT (1) ATE255590T1 (enExample)
AU (1) AU774385B2 (enExample)
BR (1) BR0013569B1 (enExample)
CA (1) CA2382497C (enExample)
CO (1) CO5190666A1 (enExample)
CZ (1) CZ2002594A3 (enExample)
DE (1) DE60006976T2 (enExample)
DK (1) DK1212336T3 (enExample)
EA (1) EA005080B1 (enExample)
ES (1) ES2209970T3 (enExample)
FR (1) FR2797875B1 (enExample)
HK (1) HK1049167B (enExample)
HR (1) HRP20020167B1 (enExample)
HU (1) HU229075B1 (enExample)
IL (2) IL148128A0 (enExample)
ME (2) ME00112B (enExample)
MX (1) MXPA02001988A (enExample)
NO (1) NO322622B1 (enExample)
PL (1) PL204100B1 (enExample)
PT (1) PT1212336E (enExample)
RS (1) RS50433B (enExample)
SI (1) SI1212336T1 (enExample)
SK (1) SK287588B6 (enExample)
TR (1) TR200200506T2 (enExample)
TW (1) TWI272949B (enExample)
UA (1) UA73523C2 (enExample)
WO (1) WO2001014393A2 (enExample)
ZA (1) ZA200201599B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
BR0215806A (pt) * 2002-07-19 2005-04-26 Aventis Pharma Sa Composição oral de telitromicina com paladar mascarado
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
CA2516733C (en) * 2003-02-21 2011-09-27 The University Of Bath Process for the production of particles
US20050014706A1 (en) * 2003-07-14 2005-01-20 Kanakeshwari Falzari Method of treating tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3468336D1 (en) * 1983-06-22 1988-02-11 Univ Ohio State Res Found Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
ME00112B (me) 2010-10-10
HK1049167B (zh) 2005-08-19
NO322622B1 (no) 2006-11-06
EP1212336B1 (fr) 2003-12-03
KR20020033771A (ko) 2002-05-07
HRP20020167B1 (en) 2006-06-30
HRP20020167A2 (en) 2003-06-30
CN1183151C (zh) 2005-01-05
YU13202A (sh) 2004-09-03
DK1212336T3 (da) 2004-03-15
BR0013569B1 (pt) 2014-02-25
SK2532002A3 (en) 2002-09-10
EA200200294A1 (ru) 2002-08-29
NO20020926L (no) 2002-02-26
WO2001014393A2 (fr) 2001-03-01
FR2797875B1 (fr) 2001-10-19
JP2003507484A (ja) 2003-02-25
HK1049167A1 (en) 2003-05-02
CZ2002594A3 (cs) 2002-09-11
TR200200506T2 (tr) 2002-08-21
AU774385B2 (en) 2004-06-24
US6825218B1 (en) 2004-11-30
IL148128A (en) 2006-10-31
TWI272949B (en) 2007-02-11
PL204100B1 (pl) 2009-12-31
AU7018100A (en) 2001-03-19
ATE255590T1 (de) 2003-12-15
CN1371386A (zh) 2002-09-25
HUP0202842A2 (hu) 2003-01-28
EP1212336A2 (fr) 2002-06-12
HUP0202842A3 (en) 2003-03-28
MEP20108A (en) 2010-06-10
KR100718222B1 (ko) 2007-05-15
RS50433B (sr) 2009-12-31
ES2209970T3 (es) 2004-07-01
CA2382497A1 (fr) 2001-03-01
ZA200201599B (en) 2003-04-30
CO5190666A1 (es) 2002-08-29
CA2382497C (fr) 2011-06-28
JP4871467B2 (ja) 2012-02-08
DE60006976D1 (de) 2004-01-15
WO2001014393A3 (fr) 2001-06-21
MXPA02001988A (es) 2002-08-20
SI1212336T1 (en) 2004-04-30
PT1212336E (pt) 2004-04-30
BR0013569A (pt) 2002-05-14
SK287588B6 (sk) 2011-03-04
PL353137A1 (en) 2003-10-20
EA005080B1 (ru) 2004-10-28
IL148128A0 (en) 2002-09-12
UA73523C2 (uk) 2005-08-15
DE60006976T2 (de) 2004-10-21
NO20020926D0 (no) 2002-02-26
HU229075B1 (hu) 2013-07-29
FR2797875A1 (fr) 2001-03-02

Similar Documents

Publication Publication Date Title
NO20024176L (no) Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
AR025398A1 (es) Aglomerados esfericos de telitromicina, su procedimiento de preparacion y su aplicacion en la preparacion de formas farmaceuticas.
PT1119557E (pt) Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
DK1037614T3 (da) Dobbeltkapsel til indgivelse af aktive bestanddele til mangfoldige terapier
PT1221918E (pt) Administracao de drogas sub-tenon
IS6348A (is) (1a,3a,5a)(3-amínómetýl bísýkló[3.2.0]hept-3-ýl)-ediksýra, lyfjasamsetningar og notkun efnasambandsins til framleiðslu á lyfjum
ATE245429T1 (de) Antitrombotische mitteln
IL193234A0 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
NO995137L (no) Fremstilling av höyaktive katalysatorer; katalysatorene og deres anvendelse
ID28709A (id) Kombinasi dari dua atau lebih bahan aktif yang menggunakan formulasi mikrokapsulasi
ATE286715T1 (de) Gastrointestinale an der mucosa haftende pharmazeutische zusammensetzung
ID27757A (id) Indolinona-indolinona tersubstitusi baru, preparasi dan penggunaannya sebagai obat
PT1083171E (pt) Derivados de pirazolina sua preparacao e aplicacao como medicamentos
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
NO20000294D0 (no) Derivater av acylpiperazinylpyrimidiner, deres fremstilling og anvendelse som legemidler
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
NO20012986D0 (no) Kontrollert frigivende formulering av natrium divalproex
AR029312A1 (es) Formas cristalinas de eto2c-ch2-(r)cgl-aze-pab-oh, procesos para su produccion, formulacion farmaceutica, y uso de estos compuestos para la elaboracion de un medicamento.
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
FI971533A0 (fi) Lyofilisoituja farmaseuttisia valmisteita, jotka kykenevät muodostamaan vesipitoisen lääkekoostumuksen, jolla on palautuvan, lämpökovettuvan geelittymisen ominaisuus
HN1998000144A (es) Formulacion medicamentosa con liberacion controlada de sustancia activa.
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
EE200200022A (et) Aminotiasooli derivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid
AR030662A1 (es) Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos
IT1227436B (it) Derivati di 1-azabicicloalcani, loro procedimento di preparazione e loro applicazione come farmaci

Legal Events

Date Code Title Description
FB Suspension of granting procedure